米诺地尔
脱发
医学
皮肤病科
安慰剂
临床试验
内科学
替代医学
病理
作者
Aditya K. Gupta,Kelly A. Foley
出处
期刊:PubMed
日期:2015-03-26
卷期号:19 (6): 5-7
被引量:14
摘要
Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. While 5% minoxidil foam has been approved for men since 2006, Health Canada and the FDA only approved 5% minoxidil foam for female pattern hair loss (FPHL) in 2014. Recent Phase III clinical trials demonstrated the efficacy of once daily 5% minoxidil foam for treatment of FPHL, where a significant change from baseline in the target area hair count was observed compared to placebo. Similar changes in hair count for 5% foam and twice daily 2% minoxidil solution established noninferiority of the 5% foam formulation. Five percent minoxidil foam provides an additional option for women with FPHL and will soon be available in Canada.
科研通智能强力驱动
Strongly Powered by AbleSci AI